Porcine collagen implant could help avoid corneal transplants

NCT ID NCT04741230

Recruiting now Disease control Sponsor: The Royal Wolverhampton Hospitals NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the Gebauer Lenticule, a tiny implant made from pig collagen, for people with severe keratoconus or post-LASIK ectasia. The implant is placed inside the cornea to strengthen it and improve stability, potentially delaying or avoiding the need for a corneal transplant. The trial will enroll 15 adults and focus on safety, tolerability, and early signs of effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Gebauer Lenticule (porcine collagen corneal implant)
What this could lead to: If successful, this implant could offer a less invasive, reversible option to strengthen the cornea and delay or avoid the need for a corneal transplant.
What could go wrong: This is a very early feasibility study with only 15 participants, so results may not apply to everyone. Risks include implant rejection, inflammation, or no improvement in vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

corneal ectasia keratoconus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KERATOCONUS POST-LASER RETINAL CONDITION

Contacts and locations

Locations

The Royal Wolverhampton NHS Trust
RECRUITING

Wolverhampton, West Midlands, WV10 0QP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.